Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
GSK Stock Climbs on Zantac Settlement
07:55am, Friday, 23'rd Jun 2023
GSK's settlement with a plaintiff in California over claims Zantac can cause cancer avoids a trial and brings it into line with industry peers.
There's a 'strong desire' in big pharma to continue to acquire, says JPMorgan analyst
07:15am, Friday, 23'rd Jun 2023
Juha Anjala, co-head of EMEA health-care investment banking at JPMorgan, discusses government support for investment in life sciences, as well as innovation in the sector.
Virgin Galactic shares tumble, while Trupanian and GSK climb and other stocks on the move
05:41am, Friday, 23'rd Jun 2023
Shares of Trupanion Inc. TRUP, -5.73% jumped 16% in premaket trading after the pet-insurance provider announced that California and New York approved double-digit rate increases, saying that the hikes
GSK shares surge after reaching settlement on Zantac ahead of California trial
05:00am, Friday, 23'rd Jun 2023
GSK GSK shares surged 6% in London action as the U.K. pharmaceutical said it reached a settlement over its Zantac heartburn medication litigation with a plaintiff in California ahead of the trial slat
GSK shares up 3.4% after Zantac settlement
03:18am, Friday, 23'rd Jun 2023
Shares in GSK PLC (LSE:GSK, NYSE:GSK) rose by 3.4% following the announcement of a confidential settlement reached by the UK pharmaceutical group concerning a US lawsuit. The case claimed that GSK's
GSK reaches settlement in U.S. Zantac litigation
02:13am, Friday, 23'rd Jun 2023
GSK Plc on Friday said it reached a confidential settlement of a litigation in the United States over claims that the British drugmaker's heartburn drug Zantac caused cancer.
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
02:06pm, Thursday, 22'nd Jun 2023
The CDC analysis suggests the shots will reduce the burden of RSV on hospitals in the fall.
GSK and Pfizer RSV jab gets US CDC backing
03:31am, Thursday, 22'nd Jun 2023
GSK PLC (LSE:GSK, NYSE:GSK) received a second dose of good this week that augers well for the roll-out of its respiratory syncytial virus (RSV) jab. An advisory committee to the US Centers for Diseas
7 Healthcare Stocks to Make You the Millionaire Next Door
08:41pm, Wednesday, 21'st Jun 2023
Investing in healthcare stocks can be a wise decision for those looking to become wealthy in the long term. Some of the best healthcare stocks to buy are firms that are developing highly effective dr
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
05:57pm, Wednesday, 21'st Jun 2023
The CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
GSK's RSV Vaccine Could Be Effective for Longer. What That Means.
02:38pm, Wednesday, 21'st Jun 2023
The drugmaker says its RSV shot prevents disease for 18 months.
GSK says RSV vaccine for older adults provides protection over two seasons
10:38am, Wednesday, 21'st Jun 2023
GlaxoSmithKline's new clinical trial results suggest seniors may only need to take the pharmaceutical company's RSV shot every other year.
RSV vaccine for older adults provides protection over two seasons, GSK says
08:40am, Wednesday, 21'st Jun 2023
GSK's GSK, -1.51% respiratory syncytial virus vaccine for older adults may protect against disease for two full RSV seasons, according to new results from a phase 3 trial the company released Wednesda
US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults
06:07am, Wednesday, 21'st Jun 2023
A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday will vote on whether to recommend the use of recently approved vaccines from Pfizer and GSK to prevent sev
RSV Vaccine For Adults Gives Long-Term Protection, GSK Says After Late-Stage Trial
06:06am, Wednesday, 21'st Jun 2023
GSK said its shot, the world's first authorized RSV vaccine, showed protection in older adults for two seasons after a single dose.
